Followers | 505 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, July 11, 2014 10:59:58 AM
bullish
$ATOS
DD Notes ~ http://www.ddnotesmaker.com/ATOS
##### recent news/filings ~ source: finance.yahoo.com
Thu, 26 Jun 2014 10:01:51 GMT ~ ATOSSA GENETICS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhib
read full: http://biz.yahoo.com/e/140626/atos8-k.html
*********************************************************
Wed, 25 Jun 2014 12:00:00 GMT ~ Atossa Genetics Receives Quality Registration Certificates ISO 13485:2003; EN ISO 13485:2012 and AC:2012 (Canadian); and ISO 9001:2008
[Marketwired] - Atossa Genetics Inc. announced today that it has received international registration for its quality management system. Atossa received registration certificates under the following standards:
read full: http://finance.yahoo.com/news/atossa-genetics-receives-quality-registration-120000690.html
*********************************************************
Mon, 16 Jun 2014 12:00:00 GMT ~ Atossa Genetics Announces Presentation at the Life Science Innovation Northwest 2014 Exposition on June 20
[Marketwired] - Atossa Genetics Inc., today announced that Steven C. Quay, M.D., Ph.D., Chairman, CEO and President will be a featured presenter at the Life Science Innovation Northwest 2014 Exposition , North America's ...
read full: http://finance.yahoo.com/news/atossa-genetics-announces-presentation-life-120000193.html
*********************************************************
Tue, 03 Jun 2014 12:00:00 GMT ~ Atossa Genetics Hires John E. Sawyer as Senior Vice President of Global Regulatory Affairs and Quality Assurance
[Marketwired] - Atossa Genetics Inc., today announced it has hired John E. Sawyer as Senior Vice President of Global Regulatory Affairs and Quality Assurance effective June 1, 2014. For the past fifteen months, Mr. Sawyer ...
read full: http://finance.yahoo.com/news/atossa-genetics-hires-john-e-120000002.html
*********************************************************
Mon, 02 Jun 2014 12:00:00 GMT ~ Atossa Genetics Announces Scientific Presentation at the 2014 American Society of Clinical Oncology (ASCO) Annual Conference on June 2
[Marketwired] - Atossa Genetics Inc., today announced that a presentation will be made at the 2014 American Society of Clinical Oncology Conference at McCormick Place, Chicago, Illinois, involving technology that has ...
read full: http://finance.yahoo.com/news/atossa-genetics-announces-scientific-presentation-120000159.html
*********************************************************
##### chart ~ source: stockcharts.com
##### chart ~ source: eoddata.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ATOS/company-info
Ticker: $ATOS
OTC Market Place: Not Available
CIK code: not found
Company name: Atossa Genetics Inc
Incorporated In:
##### extra dd links
Latest filings: http://www.otcmarkets.com/stock/ATOS/filings
Latest financials: http://www.otcmarkets.com/stock/ATOS/financials
Latest news: http://www.otcmarkets.com/stock/ATOS/news - http://finance.yahoo.com/q/h?s=ATOS+Headlines
Major holdings: http://data.cnbc.com/quotes/ATOS/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ATOS+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ATOS.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ATOS
RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=ATOS&search=search
DTCC: http://search2.dtcc.com/?q=Atossa+Genetics+Inc&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Atossa+Genetics+Inc
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Atossa+Genetics+Inc&x=0&y=0
Short Sales: http://www.otcmarkets.com/stock/ATOS/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/ATOS/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/ATOS/research
Historical Prices: http://finance.yahoo.com/q/hp?s=ATOS+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=ATOS+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=ATOS+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=ATOS+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=ATOS+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=ATOS+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=ATOS
Balance Sheet: http://finance.yahoo.com/q/bs?s=ATOS
Cash Flow: http://finance.yahoo.com/q/cf?s=ATOS+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/ATOS
Bloomberg: http://www.bloomberg.com/quote/ATOS:US
Morningstar: http://quotes.morningstar.com/stock/s?t=ATOS
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ATOS
Barchart: http://www.barchart.com/quotes/stocks/ATOS
OTC Short Report: http://otcshortreport.com/index.php?index=ATOS
Investopedia: http://www.investopedia.com/markets/stocks/ATOS/?wa=0
http://www.pennystocktweets.com/stocks/profile/ATOS
##### last known share structure ~ source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/ATOS
elditl
Recent ATOS News
- Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer • GlobeNewswire Inc. • 07/02/2024 08:15:00 PM
- Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer • GlobeNewswire Inc. • 06/28/2024 12:30:00 PM
- Atossa Set to Join Russell 3000® Index Effective June 28, 2024 • GlobeNewswire Inc. • 06/17/2024 12:30:00 PM
- Atossa to Present at the Sidoti Small-Cap Investor Conference • GlobeNewswire Inc. • 06/05/2024 12:30:00 PM
- Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model • GlobeNewswire Inc. • 05/28/2024 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/24/2024 04:15:32 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/23/2024 01:00:04 PM
- Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial • GlobeNewswire Inc. • 05/15/2024 12:30:00 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 05/14/2024 08:46:30 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/13/2024 08:05:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 01:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 01:00:12 PM
- Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 12:50:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/10/2024 01:00:05 PM
- Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines • GlobeNewswire Inc. • 05/07/2024 12:30:00 PM
- Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen • GlobeNewswire Inc. • 04/29/2024 12:30:00 PM
- Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference • GlobeNewswire Inc. • 04/11/2024 12:30:00 PM
- Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen • GlobeNewswire Inc. • 04/09/2024 03:59:00 PM
- Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/01/2024 08:00:00 PM
- Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient • GlobeNewswire Inc. • 03/19/2024 12:30:00 PM
- Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements • GlobeNewswire Inc. • 03/18/2024 12:30:00 PM
- Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors • GlobeNewswire Inc. • 03/12/2024 12:30:00 PM
- Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study • GlobeNewswire Inc. • 02/22/2024 01:30:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM